Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Clinical Study in the Treatment of Patients With Moderate Course of COVID-19
Phase 2
- Conditions
- COVID-19
- Interventions
- Drug: COVID-globulinDrug: Placebo
- First Posted Date
- 2021-04-13
- Last Posted Date
- 2021-05-14
- Lead Sponsor
- Microgen
- Target Recruit Count
- 376
- Registration Number
- NCT04842435
- Locations
- 🇷🇺
15. Municipal Autonomous Institution "Central City Clinical Hospital No. 24", Ekaterinburg, Russian Federation
🇷🇺9. State Autonomous Healthcare Institution "Professor A. F. Agafonov Republican Clinical Infectious Hospital", Kazan, Russian Federation
🇷🇺13. State Budgetary Healthcare Institution "Specialized Clinical Infectious Diseases Hospital" of the Ministry of Health of the Krasnodar Territory, Krasnodar, Russian Federation
News
No news found